CoChat

Niosomal drug delivery systems for ocular disease-recent advances and future prospects

Open access
Durak, Saliha, Esmaeili Rad, Monireh, Alp Yetisgin, Abuzer, Eda Sutova, Hande, Kutlu, Ozlem, Cetinel, Sibel, Zarrabi, Ali · 2020 · Nanomaterials

The DOI matches its Crossref record; 124 of the 126 references it cites were found in a registry or an index.

Abstract

The eye is a complex organ consisting of several protective barriers and particular defense mechanisms. Since this organ is exposed to various infections, genetic disorders, and visual impairments it is essential to provide necessary drugs through the appropriate delivery routes and vehicles. The topical route of administration, as the most commonly used approach, maybe inefficient due to low drug bioavailability. New generation safe, effective, and targeted drug delivery systems based on nanocarriers have the capability to circumvent limitations associated with the complex anatomy of the eye. Nanotechnology, through various nanoparticles like niosomes, liposomes, micelles, dendrimers, and different polymeric vesicles play an active role in ophthalmology and ocular drug delivery systems. Niosomes, which are nano-vesicles composed of non-ionic surfactants, are emerging nanocarriers in drug delivery applications due to their solution/storage stability and cost-effectiveness. Additionally, they are biocompatible, biodegradable, flexible in structure, and suitable for loading both hydrophobic and hydrophilic drugs. These characteristics make niosomes promising nanocarriers in the treatment of ocular diseases. Hereby, we review niosome based drug delivery approaches in ophthalmology starting with different preparation methods of niosomes, drug loading/release mechanisms, characterization techniques of niosome nanocarriers and eventually successful applications in the treatment of ocular disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nano10061191

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Human eye anatomy, and the drug administration routes. (1) The cornea as a main route of drug delivery to the anterior section. (2) The retinal capillary endothelium and Retinal pigment epithelium as the main barriers for systemically administered drugs. (3) An invasive strategy to gain the vitreous called intravitreal injection.
Figure 1 Human eye anatomy, and the drug administration routes. (1) The cornea as a main route of drug delivery to the anterior section. (2) The retinal capillary endothelium and Retinal pigment epithelium as the main barriers for systemically administered drugs. (3) An invasive strategy to gain the vitreous called intravitreal injection.CC BY · PubMed Central
Figure 2 Typical vesicle size of niosomes.
Figure 2 Typical vesicle size of niosomes.CC BY · PubMed Central
Figure 3 Schematic representation of the solvent injection method.
Figure 3 Schematic representation of the solvent injection method.CC BY · PubMed Central
Figure 4 Schematic representation of reverse-phase evaporation method.
Figure 4 Schematic representation of reverse-phase evaporation method.CC BY · PubMed Central
Figure 5 Schematic representation of heating method.
Figure 5 Schematic representation of heating method.CC BY · PubMed Central
Figure 6 Schematic representation of proniosome method.
Figure 6 Schematic representation of proniosome method.CC BY · PubMed Central
Figure 7 Schematic representation of (a) dialysis membrane method and (b) Franz diffusion cell method.
Figure 7 Schematic representation of (a) dialysis membrane method and (b) Franz diffusion cell method.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 124 references

Research works printed but not linked: 3

  1. More, 2019, Niosomal Drug Delivery-A Comprehensive Review, Asian J. Pharm., 12, S1159
  2. Lakshmi, 2011, Phase II study of topical niosomal urea gel-an adjuvant in the treatment of psoriasis, Int. J. Pharm. Sci. Rev. Res., 7, 1
  3. Biswas, 2017, Niosomes in ocular drug delivery, Eur. J. Pharm. Med. Res., 4, 813

Cited by

See all 198

Metadata

Authors
Durak, S., Esmaeili Rad, M., Alp Yetisgin, A., Eda Sutova, H., Kutlu, O., Cetinel, S., & Zarrabi, A.
Affiliations
  • Sabancı Üniversitesi (TR)
  • Nanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey
Corresponding author
Zarrabi, Ali
Venue
Nanomaterials
Publisher
MDPI AG
Published
2020-06-18
Volume
10
Issue
6
Pages
1191
ISSN
2079-4991 (ISSN-L)
OpenAlex
W3036547471
Cited by
196
References
126
Citations by year
2026: 26 · 2025: 35 · 2024: 44 · 2023: 40 · 2022: 27 · 2021: 22 · 2020: 2
FWCI
2.00
Type
journal article
Language
en
Open access
Locations
  • Nanomaterials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Sabanci University (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
SUNUM (I.A.SN-19-00005 (S.C.) and I.A.SN-19-00001 (A.Z.))
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
niosomes, ocular drug delivery, nonionic surfactants, nanocarriers, eye diseases, drug loading and release, niosome characterization, topical ocular administration, drug bioavailability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Niosomal drug delivery systems for ocular disease-recent advances and future prospects. https://app.cochat.ai/papers/10.3390/nano10061191
The paper
Durak, S., Esmaeili Rad, M., Alp Yetisgin, A., Eda Sutova, H., Kutlu, O., Cetinel, S., & Zarrabi, A. (2020). Niosomal drug delivery systems for ocular disease-recent advances and future prospects. Nanomaterials. https://doi.org/10.3390/nano10061191

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.